Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...

The growing elderly population is more susceptible to type 2 diabetes fuels the need for SGLT2 inhibitors in Asia Pacific. • The market segmentation is primarily based on indication, drug, ...

So you would consider things like beta blockers or calcium channel blockers ... in those patients that have a weak pump. Okay. So the SGLT2 inhibitors are one of the four pillars that we consider ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Older adults had a lower risk for major adverse CV events than younger adults with SGLT2 inhibitors. Perspective from Sara Cromer, MD SGLT2 inhibitors confer greater risk reductions for major ...

sodium-glucose transporter 2 (SGLT2) inhibitors — these reduce the amount of glucose reabsorbed by the kidneys, meaning that it is excreted in the urine. A meta-analysis, published in the ...

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...

placebo. Perspective from Shannon C. Scott, DO, FACOFP Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes ...